![These highlights do not include all the information needed to use PRALUENT safely and effectively. See full prescribing information for PRALUENT. PRALUENT® (alirocumab) injection, for subcutaneous use Initial U.S. Approval: 2015 These highlights do not include all the information needed to use PRALUENT safely and effectively. See full prescribing information for PRALUENT. PRALUENT® (alirocumab) injection, for subcutaneous use Initial U.S. Approval: 2015](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=s-praluent-04.jpg&id=563480)
These highlights do not include all the information needed to use PRALUENT safely and effectively. See full prescribing information for PRALUENT. PRALUENT® (alirocumab) injection, for subcutaneous use Initial U.S. Approval: 2015
![Praluent (Alirocumab for Solution for Subcutaneous Injection): Uses, Dosage, Side Effects, Interactions, Warning Praluent (Alirocumab for Solution for Subcutaneous Injection): Uses, Dosage, Side Effects, Interactions, Warning](https://images.rxlist.com/images/rxlist/praluent4.gif)
Praluent (Alirocumab for Solution for Subcutaneous Injection): Uses, Dosage, Side Effects, Interactions, Warning
![These highlights do not include all the information needed to use PRALUENT safely and effectively. See full prescribing information for PRALUENT. PRALUENT® (alirocumab) injection, for subcutaneous useInitial U.S. Approval: 2015 These highlights do not include all the information needed to use PRALUENT safely and effectively. See full prescribing information for PRALUENT. PRALUENT® (alirocumab) injection, for subcutaneous useInitial U.S. Approval: 2015](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=praluent-32.jpg&id=558664)
These highlights do not include all the information needed to use PRALUENT safely and effectively. See full prescribing information for PRALUENT. PRALUENT® (alirocumab) injection, for subcutaneous useInitial U.S. Approval: 2015
![These highlights do not include all the information needed to use PRALUENT safely and effectively. See full prescribing information for PRALUENT. PRALUENT® (alirocumab) injection, for subcutaneous use Initial U.S. Approval: 2015 These highlights do not include all the information needed to use PRALUENT safely and effectively. See full prescribing information for PRALUENT. PRALUENT® (alirocumab) injection, for subcutaneous use Initial U.S. Approval: 2015](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=s-praluent-33.jpg&id=563480)
These highlights do not include all the information needed to use PRALUENT safely and effectively. See full prescribing information for PRALUENT. PRALUENT® (alirocumab) injection, for subcutaneous use Initial U.S. Approval: 2015
![Your Praluent Pen | Praluent (alirocumab) website for Patients. Information on the Praluent pen, for patients prescribed Praluent Your Praluent Pen | Praluent (alirocumab) website for Patients. Information on the Praluent pen, for patients prescribed Praluent](https://www.mypraluent.co.uk/-/media/praluent-pens-3.png)